These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors. Price GW; Burton MJ; Collin LJ; Duckworth M; Gaster L; Göthert M; Jones BJ; Roberts C; Watson JM; Middlemiss DN Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):312-20. PubMed ID: 9303567 [TBL] [Abstract][Full Text] [Related]
7. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes. Newman-Tancredi A; Cussac D; Quentric Y; Touzard M; Verrièle L; Carpentier N; Millan MJ J Pharmacol Exp Ther; 2002 Nov; 303(2):815-22. PubMed ID: 12388668 [TBL] [Abstract][Full Text] [Related]
8. Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles. van Niel MB; Collins I; Beer MS; Broughton HB; Cheng SK; Goodacre SC; Heald A; Locker KL; MacLeod AM; Morrison D; Moyes CR; O'Connor D; Pike A; Rowley M; Russell MG; Sohal B; Stanton JA; Thomas S; Verrier H; Watt AP; Castro JL J Med Chem; 1999 Jun; 42(12):2087-104. PubMed ID: 10377215 [TBL] [Abstract][Full Text] [Related]
9. Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist. Doménech T; Beleta J; Palacios JM Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):328-34. PubMed ID: 9303569 [TBL] [Abstract][Full Text] [Related]
10. Discovery of 4-[3-(trans-3-dimethylaminocyclobutyl)-1H-indol-5-ylmethyl]-(4S)-oxazolidin-2-one (4991W93), a 5HT(1B/1D) receptor partial agonist and a potent inhibitor of electrically induced plasma extravasation. Jandu KS; Barrett V; Brockwell M; Cambridge D; Farrant DR; Foster C; Giles H; Glen RC; Hill AP; Hobbs H; Honey A; Martin GR; Salmon J; Smith D; Woollard P; Selwood DL J Med Chem; 2001 Mar; 44(5):681-93. PubMed ID: 11262079 [TBL] [Abstract][Full Text] [Related]
11. Importance of h5-HT1B receptor selectivity for 5-HT terminal autoreceptor activity: an in vivo microdialysis study in the freely-moving guinea-pig. Roberts C; Price GW; Gaster L; Jones BJ; Middlemiss DN; Routledge C Neuropharmacology; 1997; 36(4-5):549-57. PubMed ID: 9225280 [TBL] [Abstract][Full Text] [Related]
12. SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity. Selkirk JV; Scott C; Ho M; Burton MJ; Watson J; Gaster LM; Collin L; Jones BJ; Middlemiss DN; Price GW Br J Pharmacol; 1998 Sep; 125(1):202-8. PubMed ID: 9776361 [TBL] [Abstract][Full Text] [Related]
13. Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking. Cussac D; Newman-Tancredi A; Duqueyroix D; Pasteau V; Millan MJ Mol Pharmacol; 2002 Sep; 62(3):578-89. PubMed ID: 12181434 [TBL] [Abstract][Full Text] [Related]
15. Improvement in the selectivity and metabolic stability of the serotonin 5-HT(1A) ligand, S 15535: a series of cis- and trans-2-(arylcycloalkylamine) 1-indanols. Peglion JL; Goument B; Despaux N; Charlot V; Giraud H; Nisole C; Newman-Tancredi A; Dekeyne A; Bertrand M; Genissel P; Millan MJ J Med Chem; 2002 Jan; 45(1):165-76. PubMed ID: 11754589 [TBL] [Abstract][Full Text] [Related]
16. Imidazoline-modified benzylimidazolines as h5-HT(1D/1B) serotonergic ligands. Prisinzano T; Law H; Dukat M; Slassi A; MaClean N; Demchyshyn L; Glennon RA Bioorg Med Chem; 2001 Mar; 9(3):613-9. PubMed ID: 11310595 [TBL] [Abstract][Full Text] [Related]
17. 4-Hydroxy-1-[3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl]piperidines: selective h5-HT1D agonists for the treatment of migraine. Bourrain S; Neduvelil JG; Beer MS; Stanton JA; Showell GA; MacLeod AM Bioorg Med Chem Lett; 1999 Dec; 9(23):3369-74. PubMed ID: 10612601 [TBL] [Abstract][Full Text] [Related]